View Item 

Show simple item record

Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study
dc.contributor.authorJaiswal, Mamta
dc.contributor.authorDivers, Jasmin
dc.contributor.authorUrbina, Elaine M
dc.contributor.authorDabelea, Dana
dc.contributor.authorBell, Ronny A
dc.contributor.authorPettitt, David J
dc.contributor.authorImperatore, Giuseppina
dc.contributor.authorPihoker, Catherine
dc.contributor.authorDolan, Lawrence M
dc.contributor.authorLiese, Angela D
dc.contributor.authorMarcovina, Santica
dc.contributor.authorLinder, Barbara
dc.contributor.authorFeldman, Eva L
dc.contributor.authorPop‐busui, Rodica
dc.date.accessioned2018-05-15T20:13:29Z
dc.date.available2019-08-01T19:53:24Zen
dc.date.issued2018-06
dc.identifier.citationJaiswal, Mamta; Divers, Jasmin; Urbina, Elaine M; Dabelea, Dana; Bell, Ronny A; Pettitt, David J; Imperatore, Giuseppina; Pihoker, Catherine; Dolan, Lawrence M; Liese, Angela D; Marcovina, Santica; Linder, Barbara; Feldman, Eva L; Pop‐busui, Rodica (2018). "Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study." Pediatric Diabetes 19(4): 680-689.
dc.identifier.issn1399-543X
dc.identifier.issn1399-5448
dc.identifier.urihttps://hdl.handle.net/2027.42/143647
dc.publisherJohn Wiley & Sons A/S
dc.subject.otherprevalence
dc.subject.otherheart rate variability
dc.subject.othercardiovascular autonomic neuropathy
dc.subject.othertype 1 and type 2 diabetes
dc.titleCardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/143647/1/pedi12633_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/143647/2/pedi12633.pdf
dc.identifier.doi10.1111/pedi.12633
dc.identifier.sourcePediatric Diabetes
dc.identifier.citedreferenceNathan DM, Lachin J, Cleary P, et al. Intensive diabetes therapy and carotid intimaâ media thickness in type 1 diabetes mellitus. N Engl J Med. 2003; 348 ( 23 ): 2294 â 2303.
dc.identifier.citedreferenceDalla Pozza R, Bechtold S, Bonfig W, et al. Impaired shortâ term blood pressure regulation and autonomic dysbalance in children with type 1 diabetes mellitus. Diabetologia. 2007; 50: 2417 â 2423.
dc.identifier.citedreferenceMohsin F, Craig ME, Cusumano J, et al. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care. 2005; 28: 1974 â 1980.
dc.identifier.citedreferenceRiihimaa PH, Suominen K, Knip M, Tapanainen P, Tolonen U. Cardiovascular autonomic reactivity is decreased in adolescents with type 1 diabetes. Diabet Med. 2002; 19: 932 â 938.
dc.identifier.citedreferenceEppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006; 29 ( 6 ): 1300 â 1306.
dc.identifier.citedreferenceJaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013; 36 ( 1 ): 157 â 162.
dc.identifier.citedreferenceDabelea D, Stafford JM, Mayerâ Davis EJ, et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017; 317 ( 8 ): 825 â 835.
dc.identifier.citedreferenceMyers GL, Kimberly MM, Waymack PW, Smith SJ, Cooper GR, Sampson EJ. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem. 2000; 46: 1762 â 1772.
dc.identifier.citedreferenceDabelea D, Pihoker C, Talton JW, et al. Etiological approach to characterization of diabetes type: the SEARCH for diabetes in youth study. Diabetes Care. 2011; 34 ( 7 ): 1628 â 1633.
dc.identifier.citedreferenceTang M, Donaghue KC, Cho YH, Craig ME. Autonomic neuropathy in young people with type 1 diabetes: a systematic review. Pediatr Diabetes. 2013; 14: 239 â 248.
dc.identifier.citedreferencePopâ Busui R, Low PA, Waberski BH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications trial/epidemiology of diabetes interventions and complications study (DCCT/EDIC). Circulation. 2009; 119: 2886 â 2893.
dc.identifier.citedreferenceKempler P, Tesfaye S, Chaturvedi N, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002; 19: 900 â 909.
dc.identifier.citedreferenceGottsäter A, Ahmed M, Fernlund P, Sundkvist G. Autonomic neuropathy in type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia. Diabet Med. 1999; 16: 49 â 54.
dc.identifier.citedreferenceWitte DR, Tesfaye S, Chaturvedi N, Eaton S, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005; 48: 164 â 171.
dc.identifier.citedreferenceLarsen JR, Sjøholm H, Berg TJ, et al. Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes. Diabetes Care. 2004; 27: 963 â 966.
dc.identifier.citedreferenceThe Diabetes Control and Complications Trial Research Group. The effect of intensive therapy of diabetes on the development and progression of longâ term complications in insulinâ dependent diabetes mellitus. N Engl J Med. 1993; 329: 977 â 986.
dc.identifier.citedreferenceGaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348 ( 5 ): 383 â 393.
dc.identifier.citedreferenceAng L, Jaiswal M, Martin C, Popâ Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep. 2014; 14 ( 9 ): 528.
dc.identifier.citedreferencePrasad A, Bekker P, Tsimikas S. Advanced glycation end products and diabetic cardiovascular disease. Cardiol Rev. 2012; 20: 177 â 183.
dc.identifier.citedreferenceStandards of Medical Care in Diabetesâ 2016. Diabetes Care. 2016; 39 ( suppl 1 ): S86 â S89.
dc.identifier.citedreferenceVincent AM, Hinder LM, Popâ Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst. 2009; 14: 257 â 267.
dc.identifier.citedreferenceWiggin TD, Sullivan KA, Popâ Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009; 58 ( 7 ): 1634 â 1640.
dc.identifier.citedreferenceHur J, Sullivan KA, Pande M, et al. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain. 2011; 134 ( 11 ): 3222 â 3235.
dc.identifier.citedreferenceGinsberg HN. Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes. 1996; 45 ( 3 ): S27 â S30.
dc.identifier.citedreferenceFried LF, Forrest KY, Ellis D, et al. Lipid modulation in insulinâ dependent mellitus: effect on microvascular outcomes. J Diabetes Complications. 2001; 15 ( 3 ): 113 â 119.
dc.identifier.citedreferenceJaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD Study. Diabetes Care. 2013; 36 ( 8 ): 2351 â 2358.
dc.identifier.citedreferencePrince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ. Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care. 2010; 33 ( 3 ): 652 â 657.
dc.identifier.citedreferenceLiao D, Carnethon M, Evans G, Cascio W, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in diabetics: the ARIC Study. Am J Epidemiol. 2000; 151: S35.
dc.identifier.citedreferenceValensi P, Sachs RN, Harfouche B, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care. 2001; 24: 339 â 343.
dc.identifier.citedreferenceMaahs DM, Daniels SR, de Ferranti SD, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014; 130 ( 17 ): 1532 â 1558.
dc.identifier.citedreferencePopâ Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017; 40 ( 1 ): 136 â 154.
dc.identifier.citedreferenceSpallone V, Ziegler D, Freeman R, et al. Toronto consensus panel on diabetic neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011; 27 ( 7 ): 639 â 653.
dc.identifier.citedreferencePopâ Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res. 2011; 5 ( 4 ): 463 â 478.
dc.identifier.citedreferencePopâ Busui R, Evans GW, Gerstein HC, et al. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010; 33 ( 7 ): 1578 â 1584.
dc.identifier.citedreferenceMaser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a metaâ analysis. Diabetes Care. 2003; 26 ( 6 ): 1895 â 1901.
dc.identifier.citedreferenceYoung LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD studyâ a randomized controlled trial. JAMA. 2009; 301 ( 15 ): 1547 â 1555.
dc.identifier.citedreferencePopâ Busui R, Braffett BH, Zinman B, et al. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes Care. 2017; 40 ( 1 ): 94 â 100.
dc.identifier.citedreferencePopâ Busui R, Cleary PA, Braffett BH, et al. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (diabetes control and complications trial/ epidemiology of diabetes interventions and complications). J Am Coll Cardiol. 2013; 61 ( 4 ): 447 â 454.
dc.identifier.citedreferenceOrlov S, Cherney DZ, Popâ Busui R, et al. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol. 2015; 10 ( 7 ): 1136 â 1144.
dc.identifier.citedreferenceWheelock KM, Jaiswal M, Martin CL, et al. Cardiovascular autonomic neuropathy associates with nephropathy lesions in American Indians with type 2 diabetes. J Diabetes Complications. 2016; 30 ( 5 ): 873 â 879.
dc.identifier.citedreferenceBoysen A, Lewin MAG, Hecker W, Leichter HE, Uhlemann F. Autonomic function testing in children and adolescents with diabetes mellitus. Pediatr Diabetes. 2007; 8: 261 â 264.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
pedi12633_am.pdf
Size:
730.0KB
Format:
PDF
View/Open
Name:
pedi12633.pdf
Size:
1.010MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.